SLITRK5 is a cellular protein whose normal function appears to suppress bone formation and could be a potential new target for the treatment ofosteoporosis, according to a collaborative study conducted by Weill Cornell Medicine and NewYork-Presbyterian researchers.
Cells manifesting the SLITRK5 protein are marked with magenta (left) and a bone-forming osteoblast marker in green (center). These markers were observed in the cancellous bone in the medulla space (top) or on the outer layer covering the bone (bottom). The overlap between these two markers (right) shows that SLITRK5 is found in bone-forming osteoblasts but not in other cell types, helping to make SLITRK5 a target for skeletal disease treatment. Credit: Dr. Matthew Greenblatt and Dr. Jun Sun
There Research was published in the scientific journal Nature Communications.
Read Also
- Android has made progress on the updates (but it is not necessarily seen) Jul 10, 2020
- Ford Shelby Cobra, the Daisy concept sold at auction | FormulaPassion.it Aug 18, 2021
- Hundreds of Palestinians marched in support of escapees from an Israeli jail Sep 9, 2021
- Sonego with Alcaraz, but the rain stops everything. It is also up to Berrettini and Fognini Aug 17, 2021
- Normandy: The walrus observed in Dieppe did not reappear on Saturday Nov 21, 2022
- AECC Skin Cancer Campaign | Costa Tropical Gazette News Jul 15, 2021
- The EU imposes a millionaire fine on WhatsApp for the use of personal data Sep 3, 2021